Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Coherus BioSciences, Inc. (CHRS)

« Back to company index

CHRS Chatter Timeline

Stock Ticker for CHRS

Most Active Tweeters for CHRS

UserTweets
@confcalltran 6
@OlympiaReport 6
@TheMarketsDaily 5
@dispatchtribune 4
@macondailynews 4

Recent Tweets for CHRS

registrarjourn @registrarjourn
Zacks: Analysts Expect Coherus Biosciences Inc $CHRS Will Post Earnings of -$0.82 Per Share https://t.co/ReYrrOzvaF
January 19th 2019, 10:01pm
EnterpriseLeade @EnterpriseLeade
Zacks: Analysts Expect Coherus Biosciences Inc $CHRS Will Post Earnings of -$0.82 Per Share https://t.co/gbcws0pQZI
January 19th 2019, 10:01pm
1MinuteStock @1MinuteStock
We calculated 21-day Expected Return of $CHRS for you: 27.58% https://t.co/DgGxe2FLPt
January 19th 2019, 2:01pm
SwingTradeBot @SwingTradeBot
Recent $CHRS technical alerts: 180 Bullish Setup plus 6 more alerts... https://t.co/wHiIQEfGFn
January 19th 2019, 1:01pm
TheMarketsDaily @TheMarketsDaily
Coherus Biosciences $CHRS Trading 5.5% Higher https://t.co/zNqEKmqBCj
January 18th 2019, 10:01pm
macondailynews @macondailynews
Coherus Biosciences $CHRS Stock Price Up 5.5% https://t.co/Ipzd7S2gmX
January 18th 2019, 10:01pm
bibeypost_stock @bibeypost_stock
Charming Shoppes Inc $CHRS Institutional Investors 2018 Q3 Sentiment https://t.co/25L1cs62eq
January 18th 2019, 2:01pm
dispatchtribune @dispatchtribune
Coherus Biosciences $CHRS Trading Down 5.6% https://t.co/emrgNQhPRV
January 18th 2019, 9:01am
ThisLincolnian @ThisLincolnian
Coherus Biosciences $CHRS Trading Down 5.6% https://t.co/gAWjSrwTxs
January 18th 2019, 9:01am
TheMarketsDaily @TheMarketsDaily
Head to Head Contrast: Coherus Biosciences $CHRS vs. Windtree Therapeutics $WINT https://t.co/PFL5EEtMY8
January 18th 2019, 6:01am
WeekHerald @WeekHerald
Analysts Anticipate Coherus Biosciences Inc $CHRS Will Post Earnings of -$0.82 Per Share https://t.co/nSjXP2Fi7t
January 17th 2019, 2:01pm
OlympiaReport @OlympiaReport
Brokerages Expect Coherus Biosciences Inc $CHRS to Post -$0.82 EPS https://t.co/Dp9Tw3RywV
January 17th 2019, 2:01pm
OlympiaReport @OlympiaReport
Coherus Biosciences $CHRS Trading Down 5.6% https://t.co/5jHnBLWdI1
January 16th 2019, 8:01pm
WeekHerald @WeekHerald
Coherus Biosciences $CHRS Trading Down 5.6% https://t.co/C8YPp8zltv
January 16th 2019, 8:01pm
UlmHi @UlmHi
As Coherus Biosciences $CHRS Valuation Declined, Shareholder Longwood Capital Partners Has Boosted Its Holding; Cor… https://t.co/B4Ys75yZDi
January 16th 2019, 4:01pm
BlogYomi @BlogYomi
Tekla Capital Management Has Decreased Its Holding in Coherus Biosciences $CHRS by $1.46 Million as Share Price De… https://t.co/Bn5L0GugP6
January 16th 2019, 11:01am
thefinreviewer @thefinreviewer
Coherus Biosciences $CHRS Shareholder Rock Springs Capital Management LP Has Cut Its Holding by $320,000; Alphamark… https://t.co/jZ7n6lRPtF
January 16th 2019, 5:01am
WatchlistN @WatchlistN
Head-To-Head Comparison: Coherus Biosciences $CHRS versus Windtree Therapeutics $WINT https://t.co/3SeN9p20Ep
January 16th 2019, 2:01am
StockTexts @StockTexts
$CHRS Coherus BioSciences, Inc. SEC Filing: Form 4/A https://t.co/z8iZC2wANv
January 15th 2019, 10:01am
confcalltran @confcalltran
Coherus BioSciences, Inc.'s Chief Scientific Officer just declared owning 7,828 shares of Coher https://t.co/DnyOh25Iw0 $CHRS
January 15th 2019, 10:01am
confcalltran @confcalltran
Coherus BioSciences, Inc.'s Chief Scientific Officer just declared owning 7,828 shares of Coher https://t.co/bLTdS04OQa $CHRS
January 15th 2019, 10:01am
StockTexts @StockTexts
$CHRS Coherus BioSciences, Inc. SEC Filing: Form 3/A https://t.co/8HrBAXakKi
January 15th 2019, 10:01am
ConsumerFeed @ConsumerFeed
Coherus Biosciences Inc $CHRS Expected to Post Earnings of -$0.82 Per Share https://t.co/DLbMG0YFEh
January 15th 2019, 8:01am
confcalltran @confcalltran
Coherus BioSciences, Inc.'s Chief Scientific Officer just declared owning 10,800 shares of Cohe https://t.co/fqjHQQ5NXZ $CHRS
January 14th 2019, 4:01pm
InsiderAlertsIA @InsiderAlertsIA
$CHRS: New Insider Filing on Chief Scientific Officer VLADIMIR VEXLER: https://t.co/o5PjZaMkhq
January 14th 2019, 4:01pm
confcalltran @confcalltran
Coherus BioSciences, Inc.'s Chief Scientific Officer just declared owning 10,800 shares of Cohe https://t.co/JaHp91G3Zk $CHRS
January 14th 2019, 4:01pm
dakotafinancial @dakotafinancial
Coherus Biosciences $CHRS Rating Increased to Sell at BidaskClub https://t.co/41aP3BLHml
January 14th 2019, 2:01am
macondailynews @macondailynews
Coherus Biosciences $CHRS Rating Increased to Sell at BidaskClub https://t.co/vcdPU8wU8K
January 14th 2019, 2:01am
TheMarketsDaily @TheMarketsDaily
Coherus Biosciences Inc $CHRS Given Average Rating of “Hold” by Analysts https://t.co/L0e6NKVLnZ
January 13th 2019, 8:01pm
macondailynews @macondailynews
Analysts Set Coherus Biosciences Inc $CHRS PT at $30.75 https://t.co/YpCFllOzxp
January 13th 2019, 8:01pm
OlympiaReport @OlympiaReport
Coherus Biosciences $CHRS Lifted to “Hold” at Zacks Investment Research https://t.co/445or9hzXl
January 13th 2019, 11:01am
registrarjourn @registrarjourn
Coherus Biosciences $CHRS Upgraded by BidaskClub to “Sell” https://t.co/aZ9hpHdm2e
January 13th 2019, 11:01am
EnterpriseLeade @EnterpriseLeade
Coherus Biosciences $CHRS Upgraded by BidaskClub to “Sell” https://t.co/n8mj4pzjMz
January 13th 2019, 11:01am
dailypoliticaln @dailypoliticaln
Reviewing Coherus Biosciences $CHRS & Windtree Therapeutics $WINT https://t.co/LwZmbx42np
January 13th 2019, 7:01am
TickerReport @TickerReport
Financial Survey: Coherus Biosciences $CHRS vs. Windtree Therapeutics $WINT https://t.co/l6tXcxIlFo
January 13th 2019, 7:01am
AmericanBanking @AmericanBanking
Financial Survey: Coherus Biosciences $CHRS vs. Windtree Therapeutics $WINT https://t.co/6GlrRdJX7E #stocks
January 13th 2019, 7:01am
ThisLincolnian @ThisLincolnian
Coherus Biosciences $CHRS Rating Increased to Hold at Zacks Investment Research https://t.co/RWtZGL7w9X
January 12th 2019, 8:01pm
WeekHerald @WeekHerald
Coherus Biosciences $CHRS Raised to “Hold” at Zacks Investment Research https://t.co/3BvtWfR29W
January 12th 2019, 8:01pm
AmericanBanking @AmericanBanking
Coherus Biosciences Inc $CHRS Expected to Announce Earnings of -$0.82 Per Share https://t.co/hyL8KNrSKk #stocks
January 12th 2019, 8:01pm
TheMarketsDaily @TheMarketsDaily
Coherus Biosciences Inc $CHRS Expected to Announce Earnings of -$0.82 Per Share https://t.co/qhfm6OfI3k
January 12th 2019, 8:01pm
ZolmaxNews @ZolmaxNews
Coherus Biosciences $CHRS Lifted to Sell at BidaskClub https://t.co/9W3l2XM1Jl
January 12th 2019, 7:01pm
dailypoliticaln @dailypoliticaln
Coherus Biosciences $CHRS Stock Rating Upgraded by BidaskClub https://t.co/CLicz7PdmO
January 12th 2019, 11:01am
dispatchtribune @dispatchtribune
Coherus Biosciences $CHRS Upgraded by BidaskClub to Sell https://t.co/EatWcvPJ24
January 11th 2019, 7:01pm
OlympiaReport @OlympiaReport
Coherus Biosciences $CHRS Rating Increased to Sell at BidaskClub https://t.co/83Bs2OfHGu
January 11th 2019, 7:01pm
confcalltran @confcalltran
Entry into a Material Definitive https://t.co/6Q8WaiIMsd $CHRS
January 11th 2019, 4:01pm
TranscriptDaily @TranscriptDaily
Coherus Biosciences Inc $CHRS Given Consensus Recommendation of “Hold” by Analysts https://t.co/0URCataLpn
January 11th 2019, 3:01pm
OlympiaReport @OlympiaReport
Coherus Biosciences $CHRS – Research Analysts’ Weekly Ratings Changes https://t.co/QBXX4APc2H
January 11th 2019, 4:01am
AmericanBanking @AmericanBanking
Coherus Biosciences $CHRS – Research Analysts’ Weekly Ratings Changes https://t.co/aoYT8F4Arp #stocks
January 11th 2019, 4:01am
dispatchtribune @dispatchtribune
Coherus Biosciences $CHRS – Research Analysts’ Weekly Ratings Changes https://t.co/rw9fAbuTqM
January 11th 2019, 4:01am
dakotafinancial @dakotafinancial
Coherus Biosciences $CHRS Raised to Hold at Zacks Investment Research https://t.co/xlpJekjEjR
January 11th 2019, 2:01am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.